Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole initiation on cycle day 3 vs day 5 in polycystic ovary syndrome
IRCT201307096467N3Phase 2Completed
- Sponsor
- Vice Chancellor for Research of Mashhad University of Medical Sciences
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of letrozole in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Vice Chancellor for Research of Mashhad University of Medical Sciences. Primary endpoint: Ovulation rate. Started Mar 2010; status: completed.
02
Drugs
letrozole
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT201307096467N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201307096467N3.